Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
893 INR | +1.06% | +2.04% | -1.87% |
Sales 2024 * | 19.71B 236M | Sales 2025 * | 26.49B 318M | Capitalization | 121B 1.46B |
---|---|---|---|---|---|
Net income 2024 * | 4.1B 49.13M | Net income 2025 * | 4.38B 52.51M | EV / Sales 2024 * | 6.69 x |
Net Debt 2024 * | 10.44B 125M | Net Debt 2025 * | 11.22B 135M | EV / Sales 2025 * | 5.01 x |
P/E ratio 2024 * |
29.7
x | P/E ratio 2025 * |
27.4
x | Employees | 3,548 |
Yield 2024 * |
0.76% | Yield 2025 * |
0.77% | Free-Float | 24.65% |
Latest transcript on Eris Lifesciences Limited
1 day | +1.06% | ||
1 week | +2.04% | ||
Current month | +5.88% | ||
1 month | +5.88% | ||
3 months | +0.40% | ||
6 months | +6.28% | ||
Current year | -1.87% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 07-01-26 | |
Vijay S. Joshi
PSD | President | - | 10-04-30 |
Sachin Shah
DFI | Director of Finance/CFO | 44 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kalpana Unadkat
BRD | Director/Board Member | 53 | 21-01-04 |
Prashant Gupta
BRD | Director/Board Member | 44 | 18-04-29 |
Chief Executive Officer | 50 | 07-01-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 117 M€ | +1.11% | - | |
0.00% | 7 M€ | +1.95% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 893 | +1.06% | 58,767 |
24-04-25 | 883.6 | +1.55% | 62,936 |
24-04-24 | 870.1 | -1.46% | 37,146 |
24-04-23 | 883 | +0.16% | 67,503 |
24-04-22 | 881.6 | +0.74% | 41,772 |
Delayed Quote NSE India S.E., April 26, 2024 at 07:43 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.87% | 1.46B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ERIS Stock